Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06625983 · ClinicalTrials.gov registry record · NA

Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care

A NA study of Colorectal Cancer Screening and Shared Decision Making, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
80,000
Enrollment target
1
Study location

NCT06625983: Recruiting NA study of Colorectal Cancer Screening and Shared Decision Making, sponsored by Massachusetts General Hospital.

NCT06625983 is a NA study of Colorectal Cancer Screening and Shared Decision Making that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80,000 participants, above the 1,672-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (4685% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06625983, a NA study of Colorectal Cancer Screening and Shared Decision Making, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
80,000 participants
Enrollment target
1
Study location

Study Summary

The research question we pose is, Does a colorectal cancer (CRC) screening decision support tool offered in advance of primary care visits increase CRC screening completion rates? Our work aims to answer this question by evaluating the effectiveness of an MGB decision support tool to 1) promote informed decisions about CRC screening for average risk patients ages 45-75, 2) deploy a decision support tool as part of a primary care bundle questionnaire, and 3) support patients in completing their preferred method of CRC screening.

Primary Outcome

Assessment of electronic health record data to determine completion of CRC screening by any modality

Interventions

  • OTHER CRC decision tool

Study Locations (1)

Massachusetts

  • Mass General Brigham - Boston

Trial Details

FieldValue
Enrollment Target 80,000 participants
Start Date 2024-10-16
Est. Completion 2026-08-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06625983 shows while recruiting

NCT06625983 is an interventional study that assigns participants to a tested intervention. Its 80,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,672-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (4685% higher).

The record links to 4 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which CRC decision tool is the first listed.

NCT06625983 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06625983 about?

NCT06625983 is a clinical study titled "Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care". The research question we pose is, Does a colorectal cancer (CRC) screening decision support tool offered in advance of primary care visits increase CRC screening completion rates? Our work aims to answer this question by evaluating the effectiveness of an MGB decision support tool to 1) promote info...

What is the current status of trial NCT06625983?

This trial is currently recruiting. It is a NA study. The enrollment target is 80,000 participants. The study started on 2024-10-16. Estimated completion is 2026-08-01.

What conditions does trial NCT06625983 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening, Shared Decision Making, Decision Aid, Colorectal Cancer Control and Prevention.

What interventions are being tested in trial NCT06625983?

The interventions under investigation include: CRC decision tool (OTHER).

Who is sponsoring clinical trial NCT06625983?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06625983 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06625983's enrollment target sits among peer trials

80,000 1st of 19 higher than 19 of 19 other Colorectal Cancer Screening trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00063063 · 80,000 participants

    Generic Database of Very Low Birth Weight Infants

  • NCT05701111 · 80,800 participants · NA

    Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress

  • NCT02402244 · 75,000 participants

    Project: Every Child for Younger Patients With Cancer

  • NCT02803242 · 75,000 participants

    COPD Patient-Powered Research Network

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06625983, the US trial registry maintained by the National Library of Medicine. NCT06625983 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.